International Trade Commission
Notice is hereby given that the U.S. International Trade Commission has found a violation of section 337 and has determined to issue: a limited exclusion order prohibiting the unlicensed importation of certain dermatological treatment devices and components thereof that infringe one or more of claims 1, 9, and 22 of U.S. Patent No. 9,480,836 ("the '836 patent"); claims 11 and 16 of U.S. Patent No. 9,320,536 ("the '536 patent"); claim 14 of U.S. Patent No. 9,775,774 ("the '774 patent"); and claims 5, 13, and 18 of U.S. Patent No. 10,869,812 ("the '812 patent"); cease and desist orders against Respondents EndyMed Medical Ltd. of Caesarea, Israel; EndyMed Medical, Ltd. of New York, New York; and EndyMed Medical, Inc. of Freehold, New Jersey (collectively, "EndyMed"); and set a bond in the amount of eighty-five percent (85%) of the entered value of the EndyMed Pure, and seventy percent (70%) of the entered value of the EndyMed Pro infringing products imported during the period of Presidential review. The investigation is terminated with respect to these four patents. The Commission has also determined to reverse the presiding administrative law judge's ("ALJ") finding that asserted claims 4, 6, and 7 of U.S. Patent No. 11,406,444 ("the '444 patent") are indefinite, remand the investigation to the ALJ with respect to that patent consistent with the concurrently issued Commission opinion and remand order, and extend the target date for completion of the investigation.
Document Headings Document headings vary by document type but may contain the following: the agency or agencies that issued and signed a document the number of the CFR title and the number of each part the document amends, proposes to amend, or is directly related to the agency docket number / agency internal file number the RIN which identifies each regulatory action listed in the Unified Agenda of Federal Regulatory and Deregulatory Actions See the Document Drafting Handbook for more details. International Trade Commission [Investigation No. 337-TA-1356] AGENCY: U.S. International Trade Commission. ACTION: Notice. SUMMARY: Notice is hereby given that the U.S. International Trade Commission has found a violation of section 337 and has determined to issue: a limited exclusion order prohibiting the unlicensed importation of certain dermatological treatment devices and components thereof that infringe one or more of claims 1, 9, and 22 of U.S. Patent No. 9,480,836 (“the '836 patent”); claims 11 and 16 of U.S. Patent No. 9,320,536 (“the '536 patent”); claim 14 of U.S. Patent No. 9,775,774 (“the '774 patent”); and claims 5, 13, and 18 of U.S. Patent No. 10,869,812 (“the '812 patent”); cease and desist orders against Respondents EndyMed Medical Ltd. of Caesarea, Israel; EndyMed Medical, Ltd. of New York, New York; and EndyMed Medical, Inc. of Freehold, New Jersey (collectively, “EndyMed”); and set a bond in the amount of eighty-five percent (85%) of the entered value of the EndyMed Pure, and seventy percent (70%) of the entered value of the EndyMed Pro infringing products imported during the period of Presidential review. The investigation is terminated with respect to these four patents. The Commission has also determined to reverse the presiding administrative law judge's (“ALJ”) finding that asserted claims 4, 6, and 7 of U.S. Patent No. 11,406,444 (“the '444 patent”) are indefinite, r…
Other Federal Register documents from the same docket.
Certain Dermatological Treatment Devices and Components Thereof; Notice of Commission Determination Not To Review an Initial Determination Terminating the Remand Proceedings Based on Settlement; Termination of Investigation
Certain Dermatological Treatment Devices and Components Thereof; Notice of a Commission Determination To Institute a Rescission Proceeding and, Upon Institution, To Rescind the Remedial Orders; Termination of the Rescission Proceeding
Certain Dermatological Treatment Devices and Components Thereof; Notice of Commission Determination To Review in Part a Final Initial Determination Finding a Violation of Section 337; Request for Written Submissions on the Issues Under Review and on Remedy, the Public Interest, and Bonding
Certain Dermatological Treatment Devices and Components Thereof; Notice of Request for Submissions on the Public Interest
Certain Dermatological Treatment Devices and Components Thereof; Institution of Investigation
Citation: 90 FR 24292
